ABCG2 and metabolic dysfunction-associated steatotic liver disease: As a result, random-effect models were applied to these outcomes, confirming a causal relationship between ABCG2-mediated hyperuricemia and liver/bile duct cancer (ieu-b-4915), while excluding any such relationship with NAFLD.